|4Apr 14, 5:31 PM ET

Accordino Robert 4

4 · Ontrak, Inc. · Filed Apr 14, 2022

Insider Transaction Report

Form 4
Period: 2022-04-12
Accordino Robert
Chief Medical Officer
Transactions
  • Award

    Option (right to buy)

    2022-04-12+27,75027,750 total
    Exercise: $1.73From: 2023-04-12Exp: 2029-04-12Ontrak, Inc. Common Stock (27,750 underlying)
Footnotes (2)
  • [F1]These securities were granted to Dr. Accordino for his services as the Chief Medical Officer of the Company.
  • [F2]25% of these options shall vest one year from the date of grant and the remaining options shall vest in 12 equal quarterly installments thereafter over the next three years.

Documents

1 file
  • 4
    primary_01.xmlPrimary

    PRIMARY DOCUMENT